Skip to main content
Clinical Trials/NCT00374764
NCT00374764
Completed
N/A

Randomized Double Blind Comparison of Applied Behavioral Analysis Versus ABA and Risperidone

Washington University School of Medicine1 site in 1 country60 target enrollmentJuly 2000

Overview

Phase
N/A
Intervention
Not specified
Conditions
Autistic Disorder
Sponsor
Washington University School of Medicine
Enrollment
60
Locations
1
Status
Completed
Last Updated
19 years ago

Overview

Brief Summary

Hypotheses:

  1. Preschool children with autism spectrum disorders (ASDs) who undergo ABA treatment only will demonstrate significantly better outcomes compared to an age and severity matched control group without ABA treatment.
  2. Preschool children with ASDs who undergo ABA in combination with risperidone will demonstrate significantly better outcomes compared to age and severity matched children who are receiving ABA alone.
  3. Young age, cognitive development and attentional abilities at baseline will be predictive of good socio-emotional and neuropsychological outcomes after ABA treatment.
  4. At baseline, children with ASDs will show significantly lower performances on measures of cognitive, neuropsychological, and socio-emotional functioning than age-matched typically developing controls.
Registry
clinicaltrials.gov
Start Date
July 2000
End Date
June 2002
Last Updated
19 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of autism or severe pervasive developmental disorder (PDD) not otherwise specified (NOS) according to the Autism Diagnosis Interview-Revised (ADI-R)
  • Aged 2.6 to 5.0.

Exclusion Criteria

  • Fragile X or metabolic etiology of PDD symptoms
  • Diagnosis of other central nervous system (CNS) disorders
  • Chronic serious medical problems

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials